CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) (USD $)	6 Months Ended
	Dec. 31, 2011	Dec. 31, 2010
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Income (Loss)	$ 1,673,566	$ (488,796)
Adjustments to Reconcile Net Loss to Net Cash Used In Operating Activities -
Depreciation and Amortization	13,081	29,394
Gain on Sale of Patents	(2,276,286)
Gain on Sale of Assets	(2,149)	(29,991)
Stock-based Compensation Expense	17,900	7,185
Non-cash Interest Expense	27,708	30,000
Changes in Operating Assets and Liabilities -
Accounts Receivable, net	(14,087)	234,255
Inventories	43,888	35,097
Prepaid Expenses	(10,560)	(18,158)
Accounts Payable	(327,136)	15,006
Customer Advances	(7,713)	(65,076)
Accrued Expenses	(93,666)	(88,736)
Net Cash Used In Operating Activities	(955,454)	(339,820)
CASH FLOWS FROM INVESTING ACTIVITIES:
Net Proceeds from Sale of Patents	2,463,171
Proceeds from Sale of Assets	2,149	29,991
Additional Patent Costs	(1,724)	(6,149)
Net Cash Provided By Investing Activities	2,463,596	23,842
CASH FLOWS FROM FINANCING ACTIVITIES:
Payment of principal and interest on 10% Senior Convertible Notes	(740,972)
Purchase of treasury stock (47,398 shares)		(474)
Net Cash Used In Financing Activities	(740,972)	(474)
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	767,170	(316,452)
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	19,556	416,040
CASH AND CASH EQUIVALENTS, END OF PERIOD	786,726	99,588
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Cash Paid for Income Taxes	912	912
SUPPLEMENTAL DISCLOSURE OF NONCASH INVESTING AND FINANCING ACTIVITIES:
Issuance of common stock to satisfy deferred compensation obligations (245,326 shares)	$ 674,645